These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

288 related items for PubMed ID: 809532

  • 1. Inhibition of T-lymphocyte-mediated tumor-specific lysis by alloantisera directed against the H-2 serological specificities of the tumor.
    Germain RN, Dorf ME, Benacerraf B.
    J Exp Med; 1975 Oct 01; 142(4):1023-8. PubMed ID: 809532
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic T lymphocytes specific for I region determinants do not require interactions with H-2K or D gene products.
    Billings P, Burakoff S, Dorf ME, Benacerraf B.
    J Exp Med; 1977 May 01; 145(5):1387-92. PubMed ID: 67179
    [Abstract] [Full Text] [Related]

  • 3. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells.
    Plata F, Jongeneel V, Cerottini JC, Brunner KT.
    Eur J Immunol; 1976 Nov 01; 6(11):823-9. PubMed ID: 187429
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of cell-mediated cytolysis of trinitrophenyl-derivatized target cells by alloantisera directed to the products of the K and D loci of the H-2 complex.
    Burakoff SJ, Germain RN, Dorf ME, Benacerrah B.
    Proc Natl Acad Sci U S A; 1976 Feb 01; 73(2):625-9. PubMed ID: 1082140
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tumor immunity to murine plasma cell tumors. VII. Expression of H-2 and tumor antigens on Ig synthesis variants of MPC-11.
    Giorgi JV, Burton RC, Scott D, Warner NL.
    Int J Cancer; 1982 Jan 15; 29(1):119-26. PubMed ID: 6977499
    [Abstract] [Full Text] [Related]

  • 19. Cell-mediated lympholysis of trinitrophenyl-modified autologous lymphocytes. Effector cell specificity to modified cell surface components controlled by H-2K and H-2D serological regions of the murine major histocompatibility complex.
    Shearer GM, Rehn TG, Garbarino CA.
    J Exp Med; 1975 Jun 01; 141(6):1348-64. PubMed ID: 47900
    [Abstract] [Full Text] [Related]

  • 20. Differential resistance to growth of a tumor expressing incompatible minor alloantigens reflects regulatory influences rather than differences in anti-minor-CTL-P frequencies.
    Carayanniotis G, Halloran PF.
    Cell Immunol; 1985 Mar 01; 91(1):100-10. PubMed ID: 2857596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.